Modelling subcutaneous absorption of U100 and U300 insulin GLARGINE in type 1 diabetes Read more about Modelling subcutaneous absorption of U100 and U300 insulin GLARGINE in type 1 diabetes
Cost-effectiveness of insulin GLARGINE 300 Units/ML (GLA-300) VS Insulin DEGLUDEC 100 Units/ML (IDEG) in T2D Read more about Cost-effectiveness of insulin GLARGINE 300 Units/ML (GLA-300) VS Insulin DEGLUDEC 100 Units/ML (IDEG) in T2D
Achievement of HbA1c targets in the diabetes unmet need with basal insulin Evaluation (DUNE) real-world study Read more about Achievement of HbA1c targets in the diabetes unmet need with basal insulin Evaluation (DUNE) real-world study
Onset 1: efficacy and safety of mealtime fast‑acting insulin aspart versus insulin aspart after 52 weeks Read more about Onset 1: efficacy and safety of mealtime fast‑acting insulin aspart versus insulin aspart after 52 weeks
Lower glucose variability and risk for hypoglycaemia on insulin Glargine 300 U/mL versus insulin Glargine 100 U/mL, evaluated by the low blood glucose index in randomized phase lll clinical crials Read more about Lower glucose variability and risk for hypoglycaemia on insulin Glargine 300 U/mL versus insulin Glargine 100 U/mL, evaluated by the low blood glucose index in randomized phase lll clinical crials
Longer acting basal insulin analogues ‘Toujeo’ and ‘Tresiba’ reduce treatment side effects; a therapeutic advance in selected patients Read more about Longer acting basal insulin analogues ‘Toujeo’ and ‘Tresiba’ reduce treatment side effects; a therapeutic advance in selected patients
Efficacy and safety of insulin degludec/liraglutide (IDegLira) vs. basal–bolus therapy in patients with type 2 diabetes: DUAL VII trial Read more about Efficacy and safety of insulin degludec/liraglutide (IDegLira) vs. basal–bolus therapy in patients with type 2 diabetes: DUAL VII trial
Day-to-day variability of fasting self-measured blood glucose associates with risk of hypoglycaemia in adults with type 1 and type 2 diabetes Read more about Day-to-day variability of fasting self-measured blood glucose associates with risk of hypoglycaemia in adults with type 1 and type 2 diabetes
Posters Autumn 2017 Read more about Posters Autumn 2017Log in or register to post comments Association of British Clinicial Diabetologists Autumn Meeting BMA House, London 9th & 10th November 2017 POSTERS FOR ONLINE VIEWING Pagination First Previous … Page 124 Page 125 Page 126 Page 127 128 Page 129 Page 130 Page 131 Page 132 … Next Last Subscribe to The Association of British Clinical Diabetologists Main navigation About Reach and Representation Committee Member Memorial Overview Professional Development Consultant Development Programme Personal Development Diabetes & Endocrine Trainees Mentorship Overview Events Submit an Abstract Webinars Event Archive Event Terms and Conditions Overview Resources Position Papers and Guidelines Joint British Diabetes Societies Rowan Hillson Awards Overview Audits ABCD Closed-Loop Audit ABCD NHS England Nationwide Closed Loop Pilot Audit ABCD Dexcom Audit ABCD FreeStyle Libre Audit ABCD Testosterone & Diabetes Worldwide Audit ABCD Oral Semaglutide Audit ABCD Semaglutide Audit ABCD EndoBarrier Worldwide Registry Audit Publications Grants Diabetes Dragons' Den Research Grants Travel Grants Overview DTN-UK About DTN-UK Join the Diabetes Technology Network UK (DTN-UK) Videos Resources Events Best Practice Guides and Top Tips Links to HCP education resources Committee Overview British Journal of Diabetes Search Search the Association of British Clinical Diabetologists Search User account menu Back to the ABCD Home page Become a member Log in